adamantane has been researched along with tretinoin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadara, H; Lotan, D; Lotan, R; Pisano, C; Schroeder, CP | 1 |
| Barzago, MM; Carminati, P; Dallavalle, S; Diomede, L; Fratelli, M; Garattini, E; Giannì, M; Kurosaki, M; Merlini, L; Parrella, E; Pisano, C; Raska, I; Rochette-Egly, C; Tavecchio, M; Terao, M | 1 |
| Barone, G; Carminati, P; D'Incalci, M; Di Francesco, AM; Meco, D; Pisano, C; Riccardi, R; Torella, AR | 1 |
| Barone, G; Cusano, G; D'Incalci, M; Di Francesco, AM; Meco, D; Pierri, F; Pisano, C; Riccardi, R; Torella, AR; Ubezio, P | 1 |
| Cusano, G; Di Francesco, AM; Falconi, M; Franzese, O; Orienti, I; Riccardi, R; Vesci, L | 1 |
5 other study(ies) available for adamantane and tretinoin
| Article | Year |
|---|---|
Induction of GDF-15/NAG-1/MIC-1 in human lung carcinoma cells by retinoid-related molecules and assessment of its role in apoptosis.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Large Cell; Cinnamates; Cytokines; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Lung Neoplasms; Oncogene Proteins, Viral; Poly(ADP-ribose) Polymerases; Repressor Proteins; Retinoids; RNA, Small Interfering; Tretinoin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2006 |
Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamm
Topics: Adamantane; Animals; Antineoplastic Agents; Calcium; Cell Death; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Cinnamates; COS Cells; Cytosol; Disease Models, Animal; G2 Phase; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Mitosis; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; RNA, Messenger; Teratocarcinoma; Tretinoin | 2006 |
The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
Topics: Adamantane; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cinnamates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Nude; Molecular Structure; Neuroblastoma; Tretinoin | 2007 |
Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models.
Topics: Adamantane; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspase 3; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cinnamates; DNA Damage; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Flow Cytometry; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Models, Biological; Neuroblastoma; Propidium; Receptors, Death Domain; Tretinoin | 2012 |
Resistance to the atypical retinoid ST1926 in SK-N-AS cells selected the subline rAS-ST with enhanced sensitivity to ATRA mediated by not conventional mechanisms: DNA damage, G2 accumulation and late telomerase inhibition.
Topics: Adamantane; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cinnamates; Comet Assay; DNA Damage; Drug Resistance, Neoplasm; Humans; Proto-Oncogene Proteins c-akt; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Telomerase; Tretinoin | 2015 |